scholarly journals MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs

Oncotarget ◽  
2021 ◽  
Vol 12 (3) ◽  
pp. 185-198
Author(s):  
Louie Semaan ◽  
Qingning Zeng ◽  
Yong Lu ◽  
Yi Zhang ◽  
Mehdi Mohamad Zreik ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Endothelial Cells ◽  
Cancer Drugs ◽  
Cerebral Endothelial Cells ◽  
Anti Cancer

scholarly journals Cancer stem-like sphere cells induced from de-differentiated hepatocellular carcinoma-derived cell lines possess the resistance to anti-cancer drugs

BMC Cancer ◽  
2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Noriaki Hashimoto ◽  
Ryouichi Tsunedomi ◽  
Kiyoshi Yoshimura ◽  
Yusaku Watanabe ◽  
Shoichi Hazama ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Cell Lines ◽  
Cancer Drugs ◽  
Anti Cancer

scholarly journals Cytotoxicity of Anti-Cancer Drugs to Vascular Endothelial Cells and Inhibitory Effect of PGE.

1998 ◽  
Vol 24 (1) ◽  
pp. 13-21 ◽  
Author(s):  
Shoji HASHIMOTO ◽  
Tsuyoshi KUROKAWA ◽  
Toshiaki NONAMI ◽  
Akio HARADA ◽  
Akimasa NAKAO ◽  
...  
Keyword(s):  
Endothelial Cells ◽  
Vascular Endothelial Cells ◽  
Inhibitory Effect ◽  
Vascular Endothelial ◽  
Cancer Drugs ◽  
Anti Cancer

A Case of Malignant Melanoma Treated with a Combination of Anti-Cancer Drugs and Biological Response Modifiers.

1993 ◽  
Vol 55 (1) ◽  
pp. 43-46
Author(s):  
Jun YOSHIDA ◽  
Juichiro NAKAYAMA ◽  
Nobuyuki SHIMIZU ◽  
Shonosuke NAGAE ◽  
Yoshiaki HORI
Keyword(s):  
Malignant Melanoma ◽  
Biological Response ◽  
Biological Response Modifiers ◽  
Cancer Drugs ◽  
Anti Cancer

Current Scenario in Structure and Ligand-Based Drug Design on Anti-colon Cancer Drugs

2019 ◽  
Vol 24 (32) ◽  
pp. 3829-3841 ◽  
Author(s):  
Lakshmanan Loganathan ◽  
Karthikeyan Muthusamy
Keyword(s):  
Drug Discovery ◽  
Drug Design ◽  
Anticancer Agent ◽  
Computational Power ◽  
Cancer Drugs ◽  
Recent Advances ◽  
Anti Cancer ◽  
Drug Designing ◽  
Current Scenario ◽  
Molecular Modeling Studies

Worldwide, colorectal cancer takes up the third position in commonly detected cancer and fourth in cancer mortality. Recent progress in molecular modeling studies has led to significant success in drug discovery using structure and ligand-based methods. This study highlights aspects of the anticancer drug design. The structure and ligand-based drug design are discussed to investigate the molecular and quantum mechanics in anti-cancer drugs. Recent advances in anticancer agent identification driven by structural and molecular insights are presented. As a result, the recent advances in the field and the current scenario in drug designing of cancer drugs are discussed. This review provides information on how cancer drugs were formulated and identified using computational power by the drug discovery society.

Sign in / Sign up

Export Citation Format

Share Document